Reuters -- U.S. health regulatory staff expressed concern about several issues with Atritech Inc’s data for its Watchman heart device to prevent blood clots, including the types of patients studied and how long they were followed.
Reuters -- U.S. health regulatory staff expressed concern about several issues with Atritech Inc’s data for its Watchman heart device to prevent blood clots, including the types of patients studied and how long they were followed.